• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌中的热休克蛋白:从肿瘤发生到临床应用。

Heat shock proteins in prostate cancer: from tumorigenesis to the clinic.

机构信息

Laboratory of Oncology, Institute of Experimental Medicine and Biology of Cuyo, Scientific and Technological Centre of Mendoza, National Research Council (CONICET) and Argentina Foundation for Cancer Research, Mendoza, Argentina.

出版信息

Int J Hyperthermia. 2010;26(8):737-47. doi: 10.3109/02656731003776968. Epub 2010 Sep 21.

DOI:10.3109/02656731003776968
PMID:20858068
Abstract

The heat shock proteins (HSP) constitute a superfamily of chaperone proteins present in all cells and in all cell compartments, operating in a complex interplay with synergistic/overlapping multiplicity of functions, even though the common effect is cell protection. Several reasons explain the need for investigating HSP in prostate cancer: (1) these molecules function as chaperones of tumorigenesis accompanying the emergence of prostate cancer cells, (2) they appear as useful molecular markers associated with disease aggressiveness and with resistance to anticancer therapies including hormone therapy, radiotherapy, chemotherapy and hyperthermia, and (3) they can be used as targets for therapies. The latter can be accomplished by: (i) interrupting the interaction of HSP (mainly HSPC1) with various client proteins that are protected from degradation when chaperoned by the HSP; (ii) using the chaperone and adjuvant capabilities of certain HSP to present antigenic peptides to the immune system, so this system can recognise the prostate tumour cells as foreign to mount an effective antitumoral response; and (iii) using treatment planning models taking into account the HSP expression levels to obtain more effective therapies. In summary, the study of the HSP during tumorigenesis as well as during cancer progression, and the inclusion of treatment designs targeting HSP combined with other treatment modalities, should improve prostate cancer survival in the near future.

摘要

热休克蛋白(HSP)构成了伴侣蛋白超家族,存在于所有细胞和所有细胞区室中,与协同/重叠的多种功能进行复杂的相互作用,尽管常见的效果是细胞保护。有几个原因解释了为什么需要在前列腺癌中研究 HSP:(1)这些分子作为肿瘤发生的伴侣发挥作用,伴随着前列腺癌细胞的出现,(2)它们作为与疾病侵袭性相关的有用分子标志物出现,并与包括激素治疗、放疗、化疗和热疗在内的抗癌治疗的耐药性相关,(3)它们可以用作治疗靶点。后一种方法可以通过以下方式实现:(i)中断 HSP(主要是 HSPC1)与各种客户蛋白的相互作用,当 HSP 对其进行伴侣时,这些客户蛋白会免受降解;(ii)利用某些 HSP 的伴侣和辅助能力将抗原肽呈递给免疫系统,以便免疫系统能够识别前列腺肿瘤细胞为外来物,从而产生有效的抗肿瘤反应;(iii)使用考虑 HSP 表达水平的治疗计划模型,以获得更有效的治疗方法。总之,研究 HSP 在肿瘤发生以及癌症进展过程中的作用,以及将针对 HSP 的治疗设计与其他治疗方式相结合,应该能够在不久的将来提高前列腺癌的生存率。

相似文献

1
Heat shock proteins in prostate cancer: from tumorigenesis to the clinic.前列腺癌中的热休克蛋白:从肿瘤发生到临床应用。
Int J Hyperthermia. 2010;26(8):737-47. doi: 10.3109/02656731003776968. Epub 2010 Sep 21.
2
Heat shock protein expression independently predicts clinical outcome in prostate cancer.热休克蛋白表达可独立预测前列腺癌的临床结局。
Cancer Res. 2000 Dec 15;60(24):7099-105.
3
Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.热休克蛋白启动子介导的热导向自杀基因疗法用于胃癌治疗
Oncol Rep. 2006 Mar;15(3):629-35.
4
Heat shock proteins in cancer: chaperones of tumorigenesis.癌症中的热休克蛋白:肿瘤发生的伴侣蛋白
Trends Biochem Sci. 2006 Mar;31(3):164-72. doi: 10.1016/j.tibs.2006.01.006. Epub 2006 Feb 17.
5
Heat shock protein expression and temperature distribution in prostate tumours treated with laser irradiation and nanoshells.激光辐射和纳米壳治疗前列腺肿瘤中的热休克蛋白表达和温度分布。
Int J Hyperthermia. 2011;27(8):791-801. doi: 10.3109/02656736.2011.607485.
6
Heat shock proteins as novel therapeutic targets in cancer.热休克蛋白作为癌症中的新型治疗靶点。
In Vivo. 2008 May-Jun;22(3):311-5.
7
Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.热休克蛋白 27 通过 eIF4E 赋予前列腺癌细胞对雄激素剥夺和化疗的抗性。
Oncogene. 2010 Apr 1;29(13):1883-96. doi: 10.1038/onc.2009.479. Epub 2010 Jan 18.
8
The value of immunohistochemical research on PCNA, p53 and heat shock proteins in prostate cancer management: a review.PCNA、p53和热休克蛋白免疫组化研究在前列腺癌治疗中的价值:综述
Eur J Histochem. 2006 Jan-Mar;50(1):25-34.
9
Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells.在前列腺肿瘤发生过程中,肌营养不良聚糖表达降低,且在前列腺癌细胞中受雄激素调控。
J Cell Physiol. 2007 Nov;213(2):528-39. doi: 10.1002/jcp.21130.
10
Thermally induced injury and heat-shock protein expression in cells and tissues.细胞和组织中的热诱导损伤与热休克蛋白表达
Ann N Y Acad Sci. 2005 Dec;1066:222-42. doi: 10.1196/annals.1363.009.

引用本文的文献

1
Comprehensive analysis of heat shock protein 110, 90, 70, 60 families and tumor immune microenvironment characterization in clear cell renal cell carcinoma.透明细胞肾细胞癌中热休克蛋白110、90、70、60家族的综合分析及肿瘤免疫微环境特征
Sci Rep. 2025 Jan 2;15(1):469. doi: 10.1038/s41598-024-84834-x.
2
Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer.热休克蛋白在良性前列腺增生和前列腺癌中的作用。
Int J Mol Sci. 2022 Jan 14;23(2):897. doi: 10.3390/ijms23020897.
3
A Review of Prostate Organogenesis and a Role for iPSC-Derived Prostate Organoids to Study Prostate Development and Disease.
前列腺发生的研究综述及 iPSC 衍生的前列腺类器官在研究前列腺发育和疾病中的作用。
Int J Mol Sci. 2021 Dec 3;22(23):13097. doi: 10.3390/ijms222313097.
4
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study.HSP90 特异性近红外探针可识别侵袭性前列腺癌:从临床前模型到人体 I 期研究的转化。
Mol Cancer Ther. 2022 Jan;21(1):217-226. doi: 10.1158/1535-7163.MCT-21-0334. Epub 2021 Oct 21.
5
Membrane Interactome of a Recombinant Fragment of Human Surfactant Protein D Reveals GRP78 as a Novel Binding Partner in PC3, a Metastatic Prostate Cancer Cell Line.人表面活性蛋白 D 重组片段的膜相互作用组分析揭示 GRP78 是转移性前列腺癌细胞系 PC3 的一种新型结合伴侣。
Front Immunol. 2021 Jan 19;11:600660. doi: 10.3389/fimmu.2020.600660. eCollection 2020.
6
Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer.人类乳腺癌分子亚型中热休克蛋白的综合转录组学分析。
BMC Cancer. 2018 Jun 28;18(1):700. doi: 10.1186/s12885-018-4621-1.
7
Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges.绿茶儿茶素预防前列腺癌:当前成果与未来挑战
Antioxidants (Basel). 2017 Apr 5;6(2):26. doi: 10.3390/antiox6020026.
8
Recombinant heat shock protein 27 (HSP27/HSPB1) protects against cadmium-induced oxidative stress and toxicity in human cervical cancer cells.重组热休克蛋白27(HSP27/HSPB1)可保护人宫颈癌细胞免受镉诱导的氧化应激和毒性作用。
Cell Stress Chaperones. 2017 May;22(3):357-369. doi: 10.1007/s12192-017-0768-y. Epub 2017 Mar 24.
9
Modulating Heat Shock Proteins 70 and 90 Expression by Low Power Laser Irradiation (635nm and 780nm) in Jurkat E6.1 T-lymphocyte Leukemia Cell Line.低功率激光(635nm和780nm)照射对Jurkat E6.1 T淋巴细胞白血病细胞系中热休克蛋白70和90表达的调节作用
J Lasers Med Sci. 2015 Winter;6(1):17-21.
10
NSK-01105, a novel sorafenib derivative, inhibits human prostate tumor growth via suppression of VEGFR2/EGFR-mediated angiogenesis.新型索拉非尼衍生物NSK-01105通过抑制VEGFR2/EGFR介导的血管生成来抑制人前列腺肿瘤生长。
PLoS One. 2014 Dec 31;9(12):e115041. doi: 10.1371/journal.pone.0115041. eCollection 2014.